leisure time -WSS

leisure time

author：hotspot 2025-09-30 01:02:27 - browse：69

Dr. Peter Bach — Peter Bach, shown at the 2019 STAT summit, is now chief medical officer of Delfi. Emilie Pickering for STAT

Delfi Diagnostics, a well-funded startup in the burgeoning field of creating blood tests to detect cancer, said on Monday that it is launching a new test, FirstLook Lung, to try to identify people who could most benefit from lung cancer screening.

The approach represents a new one in the field of liquid biopsy, in which DNA fragments in blood are used to detect or learn about tumors. Grail, another company developing a blood test for cancer screening, has insisted that its product would be best used to detect multiple cancers at once. Other companies, including Exact Sciences and Freenome, are developing tests that would focus on detecting colorectal cancer. But Delfi appears to be the first to focus first on lung cancer, the leading cause of cancer death.

Delfi’s executives, in an interview with STAT, were clear that they view the initial launch as an opportunity to gather information, and not a real commercial coming out. The test will likely become available in limited ways with specific partners and will not initially be covered by insurance. Delfi declined to reveal a specific price, but said that its early access customers, which it is not yet disclosing, will be able to use FirstLook Lung for several hundred dollars. Such a rollout does not require approval from the Food and Drug Administration, which Delfi does not have.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Why do women spend more than men on medical expenses?

WSS

Mindstrong's demise and the future of mental health care

Congress may force more Covid

Shingles, which affected Dianne Feinstein, is on the rise

Obamacare plans could cover weight loss drugs

Address the ethical violations that led to 'Three Identical Strangers'

Kaiser Permanente unions announce official strike date

explore

leisure time

hotspot

Supreme Court strikes down use of affirmative action

Inequities make cancer less preventable for women: report

Medicare details structure of new drug price negotiation program

Opioid cravings were reduced by anti

In age of alternative facts, a scholarly course on calling out crap

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

Sports medicine is finally prioritizing gender equality

Medicare Advantage enrollment hits roughly 33.4 million

Medical leaders decry Supreme Court decision on affirmative action

Would Medicare drug price negotiations stall in a shutdown?

focus

Medicare Advantage enrollment hits roughly 33.4 million

Did you have Obamacare on your GOP debate bingo card?

Biogen shutters digital health group, ends Apple study, in cost cutting move

Obamacare plans could cover weight loss drugs

Listen: Who gets the credit for GLP

FDA warns medical device makers about rise in fabricated data

focus

Wikipedia

focus

entertainment